• Latest Posts

Sosei Heptares and Lilly enter agreement on diabetes and metabolic diseases

Merck contributing to Jacobio Pharma colorectal cancer clinical trial

Study of injection to treat schizophrenia to begin after $3M payment received

Beyond Biotech podcast 10: Endpoint Health, Nevrargenics, Triastek

Up to 500 new jobs as Lilly invests $2.1B in new manufacturing sites

Lilly Partners UK Immunometabolism Biotech in Deal Worth €811M


Eli Lilly Sweetens AC Immune Alzheimer’s Treatment Deal by €38M

Update: Mixed Results for Adocia as Legal Fight with Eli Lilly Comes to a Close

More News! 23 Sep 2019

AC Immune Gets €28M from Eli Lilly as Alzheimer’s Drug Hits Phase I

Insulin Combo Reduces After-Meal Sugar Spikes in Type 1 Diabetics

Novo Nordisk Gets Close to Launching the First Oral GLP-1 Drug for Diabetes

Watch Out Eli Lilly: Novo’s Diabetes Drug Ozempic Gets European Approval